摘要
肺癌是恶性肿瘤中导致人类死亡的重要原因之一,非小细胞肺癌占其中的85%,其治疗手段多样复杂。如何更好的预测患者预后,对患者治疗方案的选择尤为重要。传统预后评估方法有一定的弊端。随着新技术的发展,18F-FDG PET/CT显像更多地应用于肺癌的分期及再分期、疗效评估和预测预后。本文对18F-FDG PET/CT显像定量指标在非小细胞肺癌预后评估中的应用进行综述。
Lung cancer is one of the important causes of human death among the malignant tumors,in which non-small cell lung cancer accounts for about 85%.The treatment of lung cancer is com-plex.How to predict the prognosis of lung cancer is very important to choose better therapy methods.The traditional prognostic evaluation methods have some disadvantages.With the development of new technolo-gy,^18F-FDG PET/CT is applied to stage and re-stage,evaluate therapy effect and predict the prognosis of lung cancer.In this review,the prognosis effect of non-small eel1 lung cancer via ^18F-FDG PET/CT will be discussed.
作者
陈肖敏
张永学
兰晓莉
cancer CHEN Xiaomin;ZHANG Yongxue;LAN Xiaoli.(Department of Nuclear Medicine,Union Hospital, Tongii Medical College ,Huazhong University of Science and Technology ,Chin)
出处
《临床外科杂志》
2018年第3期234-237,共4页
Journal of Clinical Surgery
基金
华中科技大学同济医学院研究型临床医师资助计划支持(5001530008)
